tiprankstipranks
Trending News
More News >
Taysha Gene Therapies (TSHA)
NASDAQ:TSHA
US Market
Advertisement

Taysha Gene Therapies (TSHA) Financial Statements

Compare
1,161 Followers

Taysha Gene Therapies Financial Overview

Taysha Gene Therapies's market cap is currently $1.21B. The company's EPS TTM is $-0.09; its P/E ratio is ―; Taysha Gene Therapies is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Taysha Gene Therapies Earnings and Revenue History

Taysha Gene Therapies Debt to Assets

Taysha Gene Therapies Cash Flow

Taysha Gene Therapies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis